Cargando…
Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. M...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451740/ https://www.ncbi.nlm.nih.gov/pubmed/26037906 http://dx.doi.org/10.1186/s12884-015-0554-8 |
_version_ | 1782374188053430272 |
---|---|
author | Oguntunde, Olugbenga Charyeva, Zulfiya Cannon, Molly Sambisa, William Orobaton, Nosakhare Kabo, Ibrahim A Shoretire, Kamil Danladi, Saba’atu E Lawal, Nurudeen Sadauki, Habib |
author_facet | Oguntunde, Olugbenga Charyeva, Zulfiya Cannon, Molly Sambisa, William Orobaton, Nosakhare Kabo, Ibrahim A Shoretire, Kamil Danladi, Saba’atu E Lawal, Nurudeen Sadauki, Habib |
author_sort | Oguntunde, Olugbenga |
collection | PubMed |
description | BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. METHODS: Data were collected from 80 health facilities using a cross-sectional, mixed method (quantitative and qualitative) design. We assessed health facility readiness to manage PE/E and use MgSO(4) as the drug of choice, through provider interviews, in-depth interviews with facility managers and an inventory of equipment and supply in facilities. Bivariate and qualitative data analyses were performed to isolate the principal enabling factors and barriers to the management of PE/E and use of MgSO(4). RESULTS: The majority of health facility providers correctly mentioned MgSO(4) as the drug of choice for the prevention and termination of convulsions in severe PE/E (65 %). Sixty-four percent of the health facilities had service registers available. About 45 % of providers had been trained on the use of MgSO(4) for the management of PE/E. Regarding providers’ practices, 45 % of respondents indicated that MgSO(4) was used to prevent and treat convulsions in severe PE/E in their facilities. Barriers to management of PE/E included inadequate numbers of skilled providers, frequent shortages of MgSO(4), lack of essential equipment and supplies, irregular supply of electricity and water, and non-availability of guidelines and clinical protocols at the health facilities. Technical support to providers was inadequate. CONCLUSION: The study revealed that a constellation of factors adversely affect the management of PE/E and especially the use of MgSO(4) by service providers. Efforts to improve the management of PE/E in facilities should include integrated programs that substantially improve provider and facility readiness to manage PE/E for better maternal and newborn health outcomes in Northern Nigeria. |
format | Online Article Text |
id | pubmed-4451740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44517402015-06-03 Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study Oguntunde, Olugbenga Charyeva, Zulfiya Cannon, Molly Sambisa, William Orobaton, Nosakhare Kabo, Ibrahim A Shoretire, Kamil Danladi, Saba’atu E Lawal, Nurudeen Sadauki, Habib BMC Pregnancy Childbirth Research Article BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. METHODS: Data were collected from 80 health facilities using a cross-sectional, mixed method (quantitative and qualitative) design. We assessed health facility readiness to manage PE/E and use MgSO(4) as the drug of choice, through provider interviews, in-depth interviews with facility managers and an inventory of equipment and supply in facilities. Bivariate and qualitative data analyses were performed to isolate the principal enabling factors and barriers to the management of PE/E and use of MgSO(4). RESULTS: The majority of health facility providers correctly mentioned MgSO(4) as the drug of choice for the prevention and termination of convulsions in severe PE/E (65 %). Sixty-four percent of the health facilities had service registers available. About 45 % of providers had been trained on the use of MgSO(4) for the management of PE/E. Regarding providers’ practices, 45 % of respondents indicated that MgSO(4) was used to prevent and treat convulsions in severe PE/E in their facilities. Barriers to management of PE/E included inadequate numbers of skilled providers, frequent shortages of MgSO(4), lack of essential equipment and supplies, irregular supply of electricity and water, and non-availability of guidelines and clinical protocols at the health facilities. Technical support to providers was inadequate. CONCLUSION: The study revealed that a constellation of factors adversely affect the management of PE/E and especially the use of MgSO(4) by service providers. Efforts to improve the management of PE/E in facilities should include integrated programs that substantially improve provider and facility readiness to manage PE/E for better maternal and newborn health outcomes in Northern Nigeria. BioMed Central 2015-06-03 /pmc/articles/PMC4451740/ /pubmed/26037906 http://dx.doi.org/10.1186/s12884-015-0554-8 Text en © Oguntunde et al. 2015 |
spellingShingle | Research Article Oguntunde, Olugbenga Charyeva, Zulfiya Cannon, Molly Sambisa, William Orobaton, Nosakhare Kabo, Ibrahim A Shoretire, Kamil Danladi, Saba’atu E Lawal, Nurudeen Sadauki, Habib Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title | Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title_full | Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title_fullStr | Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title_full_unstemmed | Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title_short | Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study |
title_sort | factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in northern nigeria: a mixed methods study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451740/ https://www.ncbi.nlm.nih.gov/pubmed/26037906 http://dx.doi.org/10.1186/s12884-015-0554-8 |
work_keys_str_mv | AT oguntundeolugbenga factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT charyevazulfiya factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT cannonmolly factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT sambisawilliam factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT orobatonnosakhare factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT kaboibrahima factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT shoretirekamil factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT danladisabaatue factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT lawalnurudeen factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy AT sadaukihabib factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy |